Chinosol

Quick links to important sections

Chinosol

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Chinosol

What is Chinosol? Identity and Classification

Property Description
Active ingredient Oxyquinoline (or 8-Hydroxyquinoline sulfate)
Form Tablets (for solution preparation)
Pharmacological class Antiseptic and Disinfectant
Common use Topical microbial control and sanitization
Origin Synthetic

Chinosol is the trade-recognized name for a medicinal product chemically defined by its active ingredient, Oxyquinoline, which is typically formulated as the salt 8-Hydroxyquinoline sulfate. This compound is classified as a synthetic antiseptic and disinfectant agent, belonging to the Quinolines chemical group. As an antimicrobial agent, its function is strictly topical—localized to the surface of application, a key distinguishing factor from systemically absorbed drugs.

Composition, Form, and General Purpose

Oxyquinoline is a single-ingredient product most commonly supplied as tablets intended for preparing an aqueous topical solution. This preparation is specifically suitable for external application to the skin or mucous membranes. Its general purpose is to provide effective sanitization and microbial control on external tissues. The formulation is clinically recognized for being low-toxicity and suitable for sensitive areas, such as the topical application in localized hygiene procedures.

Action Principle: Why Oxyquinoline is an Antiseptic

The mechanism involves chelation, where the molecule binds with essential metal ions that microorganisms require for their growth, thus exhibiting potent bactericidal and fungicidal properties. The compound's combined actions ensure that the primary general purpose—to inhibit the growth and proliferation of a wide range of harmful microorganisms—is achieved, providing a clean environment essential for managing minor surface contamination.

What side effects are possible with Chinosol?

Possible Side Effects and Safety Information

The official safety profile for the active ingredient in Chinosol, Oxyquinoline sulfate, is defined by its chemical hazard classifications rather than by traditional clinical side-effect frequencies (such as common or rare). These government-documented classifications establish the boundaries of risk related to exposure.


Safety Profile by System-Organ Class

The regulatory documentation identifies hazards across several physiological systems:

  • Eye Disorders: Exposure is classified as a hazard that may cause serious eye damage.
  • Skin and Subcutaneous Tissue Disorders: There is a classified potential for an allergic skin reaction, also known as dermal sensitisation.
  • Central Nervous System (Systemic Hazard): The product is formally categorized as an acute toxin if swallowed, which may lead to poisoning effects on the nervous system.

Acute and Population-Specific Safety Constraints

The safety profile includes specific high-level limitations that dictate the appropriate use and handling of the compound:

Constraint Type Regulatory Statement
Acute Systemic Hazard The product is classified as toxic if swallowed, establishing a mandatory constraint against any internal administration or accidental ingestion.
Reproductive Hazard The compound carries an official classification indicating the potential that it may damage the unborn child.

These constraints define the product strictly for external, topical application only. The compound is also noted in regulatory documents for the high environmental hazard it poses to aquatic life, imposing an official safety restriction on its disposal. This safety framework structures the understanding of potential risks associated with exposure.

Overdose and Emergency Response

The official regulatory profile for Chinosol (Oxyquinoline Sulfate) overdose is strictly defined by the substance’s classification as Toxic if swallowed, establishing ingestion as a critical trigger for mandatory emergency response. Documented manifestations of acute overdose primarily involve systemic effects, including gastrointestinal signs such as vomiting and anorexia, and central nervous system (CNS) toxicity. Severe clinical outcomes listed in the regulatory profile include convulsions and loss of consciousness. Due to this acute hazard, the official regulatory instruction is to Immediately call a POISON CENTER/doctor and to seek immediate medical attention for any suspected overdose or accidental ingestion.

This urgent action is necessitated by the potential for severe, life-threatening complications, which include the formally classified risk of serious eye damage. Furthermore, the substance is identified with reproductive toxicity, indicating it May damage the unborn child. Regulatory guidance specifies that, as no specific antidote is known, the management of an overdose is restricted to symptomatic and supportive treatment. Hospital monitoring and observation are typically required to manage and mitigate potential systemic and CNS complications following acute ingestion.

Therapeutic Uses of Chinosol

What Chinosol Treats: Main Uses and Benefits

Oxyquinoline is classified as a compound with antiseptic and disinfectant properties. Its use is relevant across domains where additional symptomatic support is needed in the presence of surface microbial activity.

The solution is applied in clinical settings that involve acute or unstable symptom patterns, including minor skin injuries (such as small cuts and abrasions), localized irritation, and situations demanding hygienic support for non-specific mucosal discomfort. It is used in areas where short-term symptom management is appropriate, particularly for symptoms related to inflammatory or irritative states, which contributes to easing the overall symptom load.

“The solution is commonly used to help with symptoms related to inflammatory or irritative states and localized symptomatic discomfort.”

When symptoms become more noticeable, such as localized itching, burning, or malodor, Chinosol is considered relevant for easing these manifestations. This supportive action supports the patient during difficult episodes by easing distress during periods of heightened symptoms.


Quick Fact: Relief for Localized Irritation

Chinosol is commonly used to help with symptoms related to inflammatory or irritative states on the skin and accessible mucous membranes, offering symptomatic relief that contributes to improved comfort during symptomatic phases.

Regulatory References

  1. National Institutes of Health (NIH) Medical Subject Headings (MeSH)

Eligibility and Restrictions for Use

Regulatory documents define eligibility for Chinosol (8-hydroxyquinoline sulfate) primarily through hazard classifications and restrictions on use, as it lacks a standardized Prescribing Information for systemic human consumption.

Contraindicated Populations and Restrictions

Population Status Official Regulatory Statement
Contraindicated Individuals with known hypersensitivity to Chinosol.
Contraindicated Pregnant individuals (due to the EU GHS/CLP classification of the base compound, 8-hydroxyquinoline, as a Reproductive Toxicant Category 1B, H360D—May damage the unborn child).
Not Recommended Lactating/Breastfeeding individuals.
Restricted Use General public use is largely restricted to low-concentration topical or cosmetic applications, which must not exceed officially set maximum concentration limits (e.g., 0.3% or 0.03% in certain hair products in the EU).
Not Established Pediatric patients.

The U.S. FDA previously classified Chinosol for certain former over-the-counter uses as Not Generally Recognized As Safe and Effective (NOT GRAS/E) due to insufficient data, further limiting its established eligibility for broad consumer use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Chinosol (8-hydroxyquinoline) has a documented interaction profile primarily influenced by its inherent chemical properties, specifically its ability to chelate with metal ions. This characteristic governs the constraints placed on co-administration with other substances.


Documented Interaction Categories

Interaction Domain Practical Constraint/Requirement
Chelation-Based Interactions (Metals) Avoid simultaneous administration with medicinal products or supplements containing divalent or trivalent cations (e.g., iron, zinc). Co-administration may reduce the efficacy or absorption of either agent.
Pharmacodynamic Interactions Use with caution when combined with other agents that also possess metal-chelating activity, potentially leading to additive effects on essential trace metal levels.
pH-Dependent Absorption Co-administration with acid-reducing drugs (such as antacids or proton pump inhibitors) may alter the pH environment in the gastrointestinal tract, potentially affecting the absorption and overall systemic exposure of Chinosol salts.

Administration Requirements

To mitigate the effect of chelation, official regulatory guidance often requires a time separation (e.g., two hours) between the dosing of Chinosol and any metal-containing medicines or supplements. This procedural requirement is a key component of the interaction management strategy. No specific enzyme (CYP) or transporter-mediated interaction profiles are detailed in the standard regulatory documentation for this product.

Mechanism of Action

Modulation of Cell Growth and Survival Pathways

Chinosol acts as a metal chelator, which disrupts intracellular homeostasis and inhibits critical cell signaling cascades, including the NF-κB and MAPK pathways. This inhibition modulates gene expression for cell survival, resulting in the suppression of cell proliferation and the induction of programmed cell death (apoptosis), which constitute the drug's core physiological effects.


Targeted Pro-oxidant and Apoptotic Activity

Chinosol, often by forming a complex with trace metals like copper, functions as a pro-oxidant to generate Reactive Oxygen Species (ROS) within the cell. This surge of oxidative stress triggers the intrinsic apoptotic cascade, resulting in the controlled destruction of specified cell populations.


Downregulation of Inflammatory Mediator Production

The drug modulates transcription factors involved in the inflammatory response, significantly dampening the activation of pathways like NF-κB. This interference limits the cell's ability to synthesize and release pro-inflammatory cytokines, resulting in a downregulation of inflammatory signal transduction.

Dosage and Administration Information

How Chinosol is Used: Established Administration Guidelines

Chinosol (Oxyquinoline sulfate) administration is defined by its localized use as an antiseptic. The recognized route is strictly topical or intra-vaginal application, reflecting its localized, non-systemic function. Established protocols outline the form, delivery method, and standardized dosage patterns for use.


Administration Scope

Administration Detail Description
Route of Administration Topical (Cutaneous) or Vaginal (Intra-vaginal application)
Dosing Schedule Volume-based, such as half an applicator (2 grams). Initial courses may involve three applications per week, transitioning to a maintenance schedule of twice weekly.
Preparation Requirements Requires the use of a bulb or universal applicator for measured intra-vaginal insertion. Tablet forms necessitate prior dilution to create the working antiseptic solution.
Special Procedural Conditions The applicator must be cleaned immediately after each use. If actively attempting conception, the product must not be used within six hours before or following intercourse.

Procedural Structure and Protocol

The application protocol is defined by the requirement to use a specialized applicator to ensure the correct volume is delivered to the target site. This structures a distinct regimen that establishes both the initial loading period and the long-term maintenance frequency. Adherence to post-application handling, such as cleaning, is a standard step in the application protocol, providing a consistent process for use.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Focus and Potential Effect

Research into the drug, Chinosol (Hydroxyquinoline sulfate), is primarily focused on its investigation for use as a topical antiseptic and disinfectant. Studies examined how Chinosol interacts with the body, with one line of research relating its activity to its ability to chelate (bind) metals, which are required by some microorganisms for growth.

Key Research Areas and Findings

Historically, the use of Chinosol and its derivatives has been investigated across several areas, though the modern focus is primarily topical. Studies that have investigated its use include:

Trial Focus Scope of Investigation Key Research Outcome
Topical Use Investigated in formulations (creams, ointments) for use on the skin. Research indicated bacteriostatic (suppressing growth) and fungicidal properties against certain organisms.
Antimicrobial Investigated against various strains of bacteria and fungi in laboratory settings. Studies showed a degree of effectiveness against certain microbes, but not all species were affected.

Pharmacokinetics and Tolerability

Pharmacokinetic research focuses on how the body handles the compound, including absorption, distribution, metabolism, and elimination. Studies have shown that when used topically, the amount of Chinosol absorbed into the bloodstream may be minimal.

Research examined the compound's tolerability, particularly in topical applications. Although generally considered well-tolerated when used as directed in specific concentrations, adverse event data from long-term, high-dose oral use of a related compound (Clioquinol) were previously associated with severe neurological side effects (Subacute Myelo-Optic Neuropathy, or SMON) and led to its withdrawal from oral use in many markets. This history underscores the importance of reviewing all research findings with a healthcare professional, especially regarding systemic exposure.

Key Studies & References

  1. Harnessing the Dual Antimicrobial Mechanism of Action with Fe(8-Hydroxyquinoline)3 to Develop a Topical Ointment for Mupirocin-Resistant MRSA Infections (Mechanism/Chelation Research)

Frequently Asked Questions (FAQ)

Common questions about Chinosol (FAQ)


Q: Does Chinosol have a common alternative name?

The active ingredient in Chinosol is known chemically as Oxyquinoline sulfate, or sometimes 8-Hydroxyquinoline sulfate. This chemical name is often used in official drug databases and in formulations where the ingredient is not sold under the Chinosol trade name.


Q: Is Chinosol generally considered a 'safe' medication?

Official regulatory bodies define the safety of this product based on its intended use as a topical antiseptic. The base compound has specific hazard classifications, including being described as a potential acute toxin if swallowed and carrying a reproductive hazard warning. Due to these official constraints, its approved use is strictly limited to specific, low-concentration topical applications.


Q: How is Chinosol thought to work inside the body?

Chinosol is described as functioning primarily as a metal chelator, which means the molecule can bind to metal ions that are essential for the growth of certain microorganisms. By binding these metals, the compound is thought to disrupt the growth process, which is the basis for its antiseptic and disinfectant properties.


Q: What kind of studies have been done on Chinosol?

Official documentation references various types of research, focusing primarily on its investigation as a topical agent. Studies have examined its use in formulations, its antimicrobial activity against specific bacteria and fungi in lab settings, and pharmacokinetic studies related to its absorption into the body.


Q: What does the available research say about how well Chinosol works?

Research summarized in official documents indicates that Chinosol possesses properties that are bacteriostatic (meaning it suppresses bacterial growth) and fungicidal. These studies show a degree of effectiveness against a range of specific microbes in tested environments.


Q: What is the typical duration of treatment with Chinosol?

Official guidelines describe the treatment as typically involving an initial course of application at a certain frequency, which is then followed by a lower-frequency maintenance schedule. The overall duration of the full treatment course is not specified uniformly across all official regulatory documents.


Q: Can Chinosol be bought without a prescription?

The status of Chinosol can vary based on the specific concentration and formulation. Some formulations of the product are regulated as Prescription Only (Rx) drugs. However, the active ingredient is also used in certain lower-concentration cosmetic and over-the-counter products that do not fall under the same drug classification.


Q: Is Chinosol used for any purpose other than what's on the label?

Official regulatory documentation defines the product's sole approved purpose as topical microbial control and sanitization. No other uses for Chinosol are officially indicated or approved by major regulatory bodies.


Q: Is it common to feel tired after taking Chinosol?

Since Chinosol is intended for localized topical application, systemic side effects like generalized tiredness are not routinely listed in the standard regulatory safety profile. Official safety classifications primarily note the risk to the Central Nervous System (CNS) only if the compound is accidentally swallowed.


Q: Does Chinosol cause weight gain or loss?

Official regulatory documentation and the standard safety profile for this compound do not list weight gain or loss as a reported hazard or side effect.


Q: What happens if I miss a dose of Chinosol?

Regulatory instructions for this product focus on adherence to the procedural steps and scheduled frequency. Official regulatory documents do not routinely detail specific public instructions for managing a single missed dose of this non-systemic product.


Q: Are there any common foods or drinks that interact with Chinosol?

The official interactions section focuses mainly on avoiding co-administration with metal-containing medicines or supplements and acid-reducing drugs. There are no specific warnings listed in regulatory documents concerning interactions with common foods or beverages.


Q: Does Chinosol interact with caffeine?

Official interaction lists and warnings provided by regulatory agencies do not include caffeine as a documented interaction concern for Chinosol.


Q: Is it safe to take Chinosol with standard pain relievers like ibuprofen?

Official interaction lists and warnings provided by regulatory agencies do not specify an interaction between Chinosol and common pain relievers, such as ibuprofen or similar non-steroidal anti-inflammatory drugs (NSAIDs).


Q: Can Chinosol affect birth control pills?

Official regulatory documentation does not contain a documented interaction warning regarding Chinosol and hormonal birth control pills.


Q: What medications should definitely not be taken at the same time as Chinosol?

Official warnings describe a need for caution/separation when co-administering with metal-containing medicinal products or supplements (like iron or zinc) or agents that also possess metal-chelating activity.


Q: Is there any research looking into the long-term effects of Chinosol?

Research summaries often note the minimal systemic absorption of the topical form of Chinosol. They sometimes reference the severe neurological side effects previously associated with the historical long-term oral use of a related compound (Clioquinol), which serves to reinforce the importance of its current restricted topical use.


Q: Is Chinosol addictive or habit-forming?

Official drug classification systems do not categorize Chinosol as a controlled substance. Official documentation does not list it as an addictive or habit-forming drug.


Q: Can Chinosol be crushed or split in half?

Official administration requirements state that the tablets are intended for prior dilution to create the antiseptic solution. Therefore, crushing or splitting may be a preparatory step for dissolution, not a means for modified tablet dosing or direct ingestion.


Q: Are there any specific lifestyle changes recommended while taking Chinosol?

Official instructions include one mandatory procedural condition: the product must not be used within six hours before or following intercourse when individuals are actively attempting conception.


Q: Does Chinosol interact with alcohol?

Official interaction lists and warnings provided by regulatory agencies do not include alcohol as a documented interaction concern.


Q: Can Chinosol cause stomach upset?

The official safety profile does not list stomach upset as a potential side effect for the approved topical use. Systemic toxicity, including potential poisoning effects, is only classified if the compound is swallowed.


Q: What is the risk of having a serious allergic reaction to Chinosol?

The official safety profile identifies a classified potential for an allergic skin reaction, also known as dermal sensitisation. This is a recognized hazard associated with exposure to the compound.


Q: Is Chinosol a long-term or short-term treatment?

The product is described with a regimen that includes an initial course followed by a maintenance schedule. This suggests its use can encompass both short-term initial management and potential longer-term adherence, as defined by the individual regimen.


Q: What should I do if the side effects of Chinosol are bothering me?

Patient information components within regulatory documents typically include a descriptive instruction to contact a healthcare professional or to stop use and seek medical attention in the event of serious or persistent adverse effects.


Q: What is the official dosage range for Chinosol?

Official documentation specifies a typical single volume for application, such as half an applicator (2 grams), and provides the frequency for use. However, regulatory information does not formally define a numerical minimum-to-maximum daily or treatment-long dosage range.


Q: Are there any specific warnings listed by the FDA for Chinosol?

Yes, the U.S. FDA previously classified Chinosol for certain former over-the-counter uses as Not Generally Recognized As Safe and Effective (NOT GRAS/E) due to insufficient data, which serves as a key official U.S. specific constraint on its use.


Q: Is Chinosol available as a generic drug?

The active ingredient, Oxyquinoline, is a generic chemical. However, the product is often sold as a brand name formulation for specific approved uses. Official drug information sources generally indicate that a lower-cost generic equivalent may not be available for the entire brand-name product.


Q: Can Chinosol cause 'rebound' symptoms if stopped abruptly?

Regulatory documents for this non-systemic antiseptic product do not list or warn against the risk of rebound symptoms or withdrawal effects upon cessation of use.


Q: Is Chinosol used to prevent any conditions?

The primary description of the product's function is for microbial control and sanitization. Its role relates to the management of existing conditions or maintaining a clean topical environment, rather than serving as a form of primary prevention.


Q: Does Chinosol make you more sensitive to the sun?

Safety data assessments for the active ingredient have indicated a need to examine Phototoxicity data in the past. However, a direct, official warning for increased sun sensitivity is not routinely included in the patient information for the final drug product.


Q: Can Chinosol affect my ability to drive or operate machinery?

Official regulatory documents for this topical product do not typically include warnings regarding potential impairment of the ability to drive or operate machinery.


Q: What is the maximum dose described in official sources?

Official sources specify the typical single volume used (e.g., half an applicator/2 grams) and the maximum frequency of application (e.g., twice weekly for maintenance). However, they do not define a single, formal absolute maximum daily or lifetime dose for the product.

How should Chinosol be stored and disposed of?

Storage and Disposal Map: How to Store and Dispose of Chinosol

Official regulatory documents define the storage and disposal requirements for Chinosol (8-Hydroxyquinoline Sulfate) based on its chemical properties and hazard classification.

Storage Requirements

Condition Requirement
Temperature & Environment Store in a cool, dry, and well-ventilated place, typically below 30 C (86 F).
Protection Keep the container tightly closed. Protect the substance from moisture (as it is hygroscopic) and direct light irradiation to maintain stability.
Handling Avoid forming dust and ensure adequate ventilation. Avoid contact with the skin and eyes, and wash thoroughly after handling.

Disposal Instructions

Disposal must align with the material's hazardous classification. The product and its contaminated packaging must be disposed of at an approved waste disposal plant following all local, regional, and national hazardous waste regulations. Do not empty the substance into drains, sewers, or release it into the environment to prevent water pollution.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Chinosol found in:

A-Z Index: